Lineage Cell Therapeutics reports Q2 profit of $1.5 million…misses revenue estimates

LCTX Lineage Cell Therapeutics Inc

$1.08 +5.88%

View chart & analysis →

1. 1Lineage Cell Therapeutics (LCTX) reported a Q2 profit of $1.5 million
2. 2Net loss per share came in at 3 cents, with quarterly revenue of $1.1 million
3. 3Revenue fell short of the $5.5 million estimate from three analysts surveyed by Zacks

Source Associated Press +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →